Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
5.1.12 Literatur
Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vössen J, Fasth A et al; European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency (2003) Long term survival and hematopoietic stem-cell transplantation for immunodeficiencies: report of the European experience 1968–99. Lancet 361:553–560
Arredondo-Vega FX, Santsteban I, Richard E, Bali P, Koleilat M, Loubser M, Al-Ghonaium A et al (2002) Adenosine deaminase deficiency with mosaicism for a “second-site suppressor” of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy. Blood 99:1005–1013
Arveiler B, de Saint-Basile G, Fischer A, Griscelli C, Mandel JL (1990) Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome. Am J Hum Genet 46:906–911
Aspenstroem P, Lindberg U, Hall A (1996) Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol 6:70–75
Benkerrou M, Gougeon ML, Griscelli C, Fischer A (1990) Hypogammaglobulinémie G et A avec hypergammaglobulinémie M. A propos de 12 observations. Arch Fr Pediatr 47:345–349
Bläase RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G et al (1995) T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270:475–480
Bruton OC (1952) Agammaglobulinemia. Pediatrics 9:722–727
Buckley RH (2000) Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 343:1313–1324
Buckley RH, Fischer A (1999) Bone marrow transplantation for primary immunodeficiency diseases. In: Ochs HD, Smith CE, Puck JM (eds) Primary immunodeficiency disease. Oxford University Press, pp 459–475
Buckley RH, Schiff RI, Schiff SE, Markert L, Williams LW, Harvilleto D, Roberts JL et al (1997) Human severe combined immunodeficiency (SCID): genetic, phenotypic and functional diversity in 100 infants. Pediatr 130:378–387
Candotti F, Notarangelo L, Visconti R, O’shea J (2002) Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways. J Clin Invest 109:1261–1269
Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G et al (2000) Gene therapy of human severe combined immunodeficiency (SCID)-Xl disease. Science 288:669–672
Chapelle de la AR, Herva R, Koivisto M, Aula P (1981) A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet 57:253–256
Daw SC, Taylor C, Kraman M, Call K, Mao J, Schuffenhauser S, Meitinger T et al (1996) A common region of 10 p deleted in DiGeorge and velocardiofacial syndromes. Nature Genet 12:458–460
Derry JM, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635–644
Devriendt K, Kim AS, Mafhijs G, Frints SG, Schwartz M, Van Den Oord JJ, Verhoef GE et al (2001) Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27:313–317
DiGeorge AM (1965) A new concept of the cellular basis of immunity. J Pediatr 67:907–908
Donner M, Schwartz M, Carlsson KU, Holmberg L (1988) Hereditary X-linked thrombocytopenia maps to the same chromosomal region as the Wiskott-Aldrich syndrome. Blood 72:1849–1853
Durandy A, Honjo T (2001) Human genetic defects in class-switch recombination (hyper-IgM syndromes). Curr Opin Immunol 13:543–548
Durandy A, Hivroz C, Mazevolles F, Schiff C, Bernard F, Jouanguy E, Revy P et al (1997) Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. J Immunol 158:2576–2584
Fisher A (2000) Severe combined immunodeficiencies (SCID). Clin Exp Immunol 122:143–149
Fisher A (2001) Primary immunodeficiency diseases: an experimental model for molecular medicine. Lancet 357:1863–1869
Fischer A, Malissen B (1998) Natural and engineered disorders of lymphocyte development. Science 280:237–242
Fischer A, Malissen B (1998) Natural and engineered disorders of lymphocyte development. Science 280:237–242
Fischer A, Landais P, Friedrich W, Morgan G, Gerritsen B, Fasth A, Porta F et al (1990) European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 336:850–854
Fischer A, Landais P, Friedrich W, Gerritsen B, Fasth A, Porta F, Vellodi A et al (1994) Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for immunodeficiency. Blood 83:1149–1154
Fischer A, Cavazzana-Calvo M, De Saint Basile G, De Villartayi P, Disanto JP, Hivroz C, Rieux-Laucat F et al (1997) Naturally occurring primary immunodeficiencies of the immune system. Ann Rev Immunol 15:93–124
Fischer A, Hacein-Bey S, Cavazzana-Calvo M (2002) Gene therapy of severe combined immunodeficiencies. Nat Rev Immunol 2:615–621
Friedrich W (2002) Blutstammzelltransplantation bei primären Immundefekterkrankungen. Monatsschr Kinderheilkd 150:1188–1194
Friedrich W, Goldmann SF, Vetter U, Fliedner TM, Heymer B, Peter HH, Reisner Y et al (1984) Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow. Lancet 1:761–764
Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2:1067–1069
Giblett ER, Ammann AJ, Wara DW, Sandman R, Diamond LK (1975) Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet 1:1010–1013
Goldberg R, Motzkin B, Marion R, Scambler PJ, Shprintzen RJ (1993) Velo-cardio-facial syndrome: a review of 120 patients. Am J Med Genet 45:313–319
Gong W, Emanuel BS, Galili N, Kim DH, Roe B, Driscoll DA, Budarf ML (1997) Structural and mutational analysis of a conserved gene (DGSI) from the minimal DiGeorge syndrome critical region. Hum Mol Genet 6:267–276
Greenberg E, Eider FF, Haffner P, Northrup H, Ledbetter DH (1988) Cytogenetic findings in a prospective series of patients with DiGeorge anomaly. Am J Hum Genet 43:605–611
Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ et al (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346:1185–9
Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, Mclntyre E, Radford I et al (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348:255–256
Haynes BF, Martin ME, Kay HH, Kurtzberg J (1988) Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues. J Exp Med 168:1061–1080
Haynes BF, Denning SM (1994) Lymphopoiesis. In: Stamatoyannopoulis G, Nienhuis A, Majerus P, Varmus H (eds) Molecular basis of blood diseases, 2nd edn. Saunders, Phüadelphia, pp 425–462
Hirschhorn R (1993) Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediatr Res 33:35–41
Hirschhorn R (1995) Adenosine deaminase deficiency: molecular basis and recent developments. Clin Immunol Immunopath 76:219–227
Hirschhorn R, Israni A, Yang DR, Ownby D (1994) Somatic mosaicism for a newly identified splice site mutation in a patient with adenosine deaminase deficient immunodeficiency (ADA-CID) and spontaneous recovery. Am J Hum Genet 55:59–68
Hirschhorn R, Yang DR, Puck JM, Huie ML, Jiang CK, Kurlandsky LE (1996) Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nature Genet 13:290–295
Hitzig WH, Biro Z, Bosch H, Huser HJ (1958) Agammaglobulinämie und Alymphozytose mit Schwund des lymphatischen Gewebes. Helv Paediatr Acta 13:551–585
Ihle JN (1995) Cytokine receptor signalling. Nature 377:591–594
Johnston JA, Kawamura M, Kirken RA, Chen Y-Q, Blake TB, Shibuya K, Ortaldo JR et al (1994) Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151–153
Kameoka J, Tanaka T, Nojiama I, Schlossman SF, Morimoto C (1993) Direct association of adenosine deaminase with a T cell activation antigen CD26. Science 261:466–469
Kawamura M, McVicar DW, Johnston JA, Blake TB, Chen YQ, Lal BK, Lloyd AR et al (1994) Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci USA 91:6374–6378
Kirby ML, Gale TF, Stewart DE (1983) Neural crest cells contribute to normal aorticopulmonary septation. Science 220:1059–1061
Knobloch C, Goldmann SF, Friedrich W (1991) Limited T cell receptor diversity of transplacentally acquired maternal T cells in severe combined immunodeficiency. J Immunol 146:4157–4162
Kurlandsy LE, Webb P, Hirschhorn R (1993) Partial adenosine deaminase in an immunodeficient child. Pediatr Asthma Allergy Immunol 7:51–55
Lederman HM, Winkelstein JA (1985) X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 64:145–156
Leonard WJ, Noguchi M, Russell SM, McBride OW (1994) The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common γ chain, γc. Immunol Rev 138:61–86
Lieber MR, Grawunder U, Wu X, Yaneva M (1997) Tying loose ends: roles of KU and DNA-dependent protein kinase in the repair of double-strand breaks. Curr Opin Genet Develop 7:99–104
Ma Y, Pannicke U, Schwarz K, Lieber MR (2002) Hairpin opening and overhang processing by an artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108:781–794
Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG et al (1995) Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65–68
Malek TR, Porter BO, He YW (1999) Multiple gamma c-dependent cytokines regulate T-cell development. Immunol Today 2:71–76
Manley NR (2000) Thymus organogenesis and molecular mechanisms of thymic epithelial cell differentiation. Semin Immunol 12:421–428
Mayer L, Kwan SP, Thompson C, Ko HS, Chiorazzi N, Waldmann T, Rosen F (1986) Evidence for a defect in “switch” T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Eng J Med 314:409–413
McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Geliert M, Oettinger MA (1996) Cleavage at a V(D)J recombination signal requires only RAG 1 and RAG 2 proteins and occurs in two Steps. Cell 83:387–395
Mebius RE (2003) Organogenesis of lymphoid tissues. Nat Rev Immunol 3:292–303
Merscher S, Funke B, Epstein JA, Heyer J, Puech A, Lu MM, Xavier RJ et al (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619–629
Morgan G, Levinsky RJ, Hugh-Jones K, Fairbanks LD, Morris GS, Simmonds HA (1987) Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency. Clin Exp Immunol 70:491
Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F, Tezcan I et al (2001) Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177–186
Moshous D, Callebaut I, de Chasseval R, Poinsignon C, Villey I, Fischer A, de Villartay JP (2003) The V(D)J recombination/DNA repair factor artemis belongs to the metal-lo-ss-lactamase family and constitutes a critical developmental Checkpoint of the lymphoid system. Ann NY Acad Sci 987:150–157
Müller SM, Ege M, Pottharst A, Schulz AS, Schwarz K, Friedrich W (2001) Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 98:1847–1851
Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW et al (1993) Interleukin receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147–157
Notarangelo LD, Düse M, Ugazio AG (1992) Immunodeficiency with hyper-IgM (HIGM). Immunodef Rev 3:101–122
Notarangelo LD, Vüla A, Schwarz K (1999) RAG and RAG defects. Curr Opin Immunol 11:435–442
O’Reilly RJ, Small TN, Friedrich W (1999) Hematopoietic cell transplant for immunodeficiency diseases. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantation, 2nd edn. Blackwell, Maiden MA, pp 1154–1172
Ochs HD, Smith CIE (1996) X-linked agammaglobulinemia: a clinical and molecular analysis. Medicine 75:287–299
Ochs HD, Smith CE, Puck JM (1999) Primary immunodeficiency disease. Oxford University Press, pp 459–475
Öttinger MA, Stanger B, Schatz DG, Glaser T, Call K, Housman D, Baltimore D (1992) The recombination activating genes, RAG 1 and RAG 2, are on chromosome 11p in humans and chromosome 2p in mice. Immunogenetics 35:97–101
Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, Honjo T (2003) Constitutive expression of AID leads to tumorigenesis. J Exp Med 197:1173–1181
Owen JJ, Moore NC (1995) Thymocyte-stromal-cell interactions and T-cell selection. Immunol Today 16:336–338
Parolini O, Ressmann G, Haas OA, Pawlowsky J, Gadner H, Knapp W, Holter W (1998) X-linked Wiskott-Aldrich syndrome in a girl. N Engl J Med 338:291–295
Perez E, Sullivan KE (2002) Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr 14:678–683
Perry GS III, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, Hanson MR et al (1980) The Wiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr 97:72–78
Pollack S, Kirkpatrick D, Kapoor N, Dupont B, O’Reilly R (1982) Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 307:662–665
Puck JM, Deschenes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, Henthorn PS (1993) The interleukin-2 receptor γ chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Molec Genet 2:1099–1104
Puck JM, De Saint-Basile G, Schwarz K, Fugmann S, Fischer RE (1996) ILRGbase: a database of γc-chain defects causing human X-SCID. Immunol Today 17:507–511
Rawlings DJ, Witte ON (1994) Bruton’s tyrosine kinase is a key regulator in B-cell development. Immun Rev 138:105–119
Remold-O’Donnell E, Rosen FS, Kenney DM (1996) Defects in Wiskott-Aldrich syndrome blood cells. Blood 87:2621–2631
Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N et al (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102:565–575
Riedy MC, Dutra AS, Blake TB, Modi W, Lal BK, Davis J, Bosse A et al (1996) Genomic sequence, organization, and chromosomal localization of human JAK3. Genomics 37:57–61
Rocca B, Bellacosa A, De Cristofaro R, Neri G, Della Ventura M, Maggiano N, Rumi C et al (1996) Wiskott-Aldrich syndrome: report of an autosomal dominant variant. Blood 87:4538–4543
Rosen FS, Cooper MD, Wedgewood RJ (1995) The primary immunodeficiencies. N Engl J Med 333:431–440
Rosen FS (1997) Severe combined immunodeficiency: a pediatric emergency. J Pediatr 130:345–346
Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS et al (1995) Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797–800
Sakamoto M, Kanegane H, Fujii H, Tsukada S, Miyawaki T, Shinomiya N (2001) Maternal germinal mosaicism of X-linked agammaglobulinemia. Am J Med Genet 99:234–237
Saint-Basile de GD, Arveiler B, Oberle I, Malcom S, Levinsky RJ, Lau YL, Hofker M et al (1987) Close linkage of the locus for X-chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-Xq13. Proc Natl Acad Sci USA 84:7576
Saint-Basile de GD, Tabone MD, Durandy A, Phan F, Fischer A, LeDeist F (1999) CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization. Eur J Immunol 29:367–373
Schatz DG, Öttinger MA, Baltimore D (1989) The V(D)J recombination activating gene, RAG-1. Cell 59:1035–1048
Schwarz K, Bartram CR (1996) V(D)J recombination pathology. Adv Immunol 61:285–326
Schwarz K, Hameister H, Gessler M, Grzeschik K-H, Hansen-Hagge TE, Bartram CR (1994) Confirmation of the localization of the human recombination activating gene 1 (RAG 1) to chromosome 11p13. Hum Genet 93:215–217
Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W et al (1996a) RAG mutations in human B cell-negative SCID. Science 274:97–99
Schwarz K, Nonoyama S, Peitsch MC, de Saint Basile G, Espanol T, Fasth A, Fischer A et al (1996b) WASPbase: a database of WAS-and XLT-causing mutations. Immunol Today 17:496–502
Schwarz K, Pannike U, Fugmann SD, Bartram CR (1999) Angeborene lymphozytäre Immundefekte. In: Ruckpaul K, Ganten D (Hrsg) Immunsystem und Infektiologie. Handbuch der molekularen Medizin und Gentherapie, Bd 4. Springer, Berlin Heidelberg New York Tokio, S 40–83
Smith CE, Witte OE (1999) in: Ochs HD, Smith CE, Puck JM (eds) Primary immunodeficiency disease. Oxford University Press, pp 263–284
Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, de Saint Basile G, Durandy A et al (1993) Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 cases. J Pediatr 123:5047–5072
Stephan V, Wahn V, LeDeist F, Dirksen U, Broker B, Muller-Fleckenstein I, Horneff G et al (1996) Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med 335:1563–1567
Sullivan KE, Müllen CA, Bläse RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876–885
Symons M, Derry JM, Karlak B, Jiangs S, Lemahieu V, McCormick F, Francke U et al (1996) Wiskott-Aldrich syndrome protein, a novel effector for the GTPase Cdc42Hs, is implicated in actin polymerization. Cell 84:723–734
Taniguchi T (1995) Cytokine signalling through nonreceptor protein tyrosine kinases. Science 268:251–255
Thrasher AJ (2002) WASP in immune-system, organization and funetion. Nat Rev Immunol 2:635–646
Thrasher AJ, Kinnon C (2000) The Wiskott-Aldrich syndrome. Clin Exp Immunol 120:2–9
Ting SS, Ziegler J, Leigh D, Kemp A, Lindeman R (1998) Mosaicism in X-linked severe combined immunodeficiency. J Pediatr 133:575–576
Vetrie D, Vörechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarstrom L et al (1993) The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosin kinases. Nature 361:226–233
Vihinen M, Iwata T, Kinnon C, Kwan SP, Ochs HD, Vörechovsky I, Smith CIE (1996) BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res 24:160–165
Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, Gatta LB et al (1998) Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93:885–896
Wada T, Konno A, Schurman SH, Garabedian EK, Anderson SM, Kirby M, Nelson DL et al (2003) Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J Clin Invest 111:1389–1397
WHO Scientific Group Report (1999) Primary immunodeficiency diseases. Clin Exp Immunol 118:1–34
Wintrobe MM (1967) The origin and development of the cells of the blood in the embryo, infant and adult. In: Wintrobe MM (ed) Clinical hematology. Lea & Febiger, Philadelphia, pp 1–62
Witthuhn BA, Silvenoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN (1994) Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153–157
Zhu Q, Watanabe C, Liu T, Hollenbaugh D, Blase RM, Kanner SB, Aruffo A, Ochs HD (1997) Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP mutations, protein expression and phenotype. Blood 90:2680–2689
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Friedrich, W., Schwarz, K. (2005). Störungen der Reifung und Differenzierung des Immunsystems als Krankheitsursache. In: Ganten, D., Ruckpaul, K. (eds) Molekularmedizinische Grundlagen von fetalen und neonatalen Erkrankungen. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26524-4_17
Download citation
DOI: https://doi.org/10.1007/3-540-26524-4_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-20138-0
Online ISBN: 978-3-540-26524-5
eBook Packages: Life Science and Basic Disciplines (German Language)